title: Glitazones and heart failure: critical appraisal for the clinician.
authors.affiliation: Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Canada.
authors.forename: Chao-Hung
authors.initials: CH
authors.lastname: Wang
authors.forename: Richard D
authors.initials: RD
authors.lastname: Weisel
authors.forename: Peter P
authors.initials: PP
authors.lastname: Liu
authors.forename: Paul W M
authors.initials: PW
authors.lastname: Fedak
authors.forename: Subodh
authors.initials: S
authors.lastname: Verma
mesh_terms: D000075202:Contraindications; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006333:Heart Failure / Q000139:chemically induced / Q000517:prevention & control*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D017202:Myocardial Ischemia / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy; D009206:Myocardium / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D007004:Hypoglycemic Agents; D018377:Neurotransmitter Agents; D013844:Thiazoles